November 12, 2009 (FinancialWire) — Nucryst Pharmaceuticals Corporation (NASDAQ: NCST) was one of the top three stocks among yesterday’s combined NYSE, NASDAQ and AMEX 25 greatest percentage winners, trading on volume of 326,296 shares and gaining $12.8 million.

Nucryst Pharmaceuticals Corp. engages in the manufacture, research, development, and commercialization of medical products in Canada and the United States. The company develops medical products based on its noble metal nanocrystalline technology, which fight infection and inflammation. It produces nanocrystalline silver as a coating for wound care products under the Silcryst name, and as a powder, known as NPI 32101, for use in medical devices and as an active pharmaceutical ingredient. The company licenses Smith & Nephew plc the exclusive right to market, distribute, and sell products with company’s Silcryst technology for use on non-minor skin wounds and burns.

Additional information about yesterday’s NYSE/NASDAQ/AMEX market activity is available via today’s “FirstAlert(tm) Money Index Synopsis” (http://www.financialwire.net/2009/11/12/firstalert-money-index-synopsis-7), which is an indicator of the depth of market direction or indirection. While not always including the same stocks, the NYSE/NASDAQ/AMEX 25 most actives and NYSE/NASDAQ/AMEX greatest percentage losers and greatest percentage winners (weighted against pure monetary loss/gain) indicate the direction in which the mass of money is flowing, as well as the general focus of the market.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.